Is Viking Therapeutics a Buy on the Dip?
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Axon reports Q3 2024 revenue of $544 million, up 32% year over year, raises outlook
Axon Cloud & Services revenue grows 36% to $203 million Annual recurring revenue grows 36% to $885 million Net income of $67 million supports non-GAAP net income of $113 million and Adjusted EBITDA of ...